Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis

Multiple Sclerosis (MS), a leading neurological disorder of young adults, is characterized by the loss of oligodendrocytes (OLs), demyelination, inflammation and neuronal degeneration. Here we show that dynamin-related protein 1 (Drpl), a mitochondrial fission protein, is activated in primary OL cells exposed to TNF-alpha induced inflammation or oxidative stress, as well as in EAE-immunized and cuprizone toxicity-induced demyelinating mouse models. Inhibition of Drp1 hyper-activation by the selective inhibitor P110 abolishes Drpl translocation to the mitochondria, reduces mitochondrial fragmentation and stems necrosis in primary OLs exposed to TNF-a and H2O2. Notably, in both types of mouse models, treatment with P110 significantly reduces the loss of mature OLs and demyelination, attenuates the number of active microglial cells and astrocytes, yet has no effect on the differentiation of oligodendrocyte precursor cells. Drpl activation appears to be mediated through the RIPK1/RIPIC3/MLKL/PGAM5 pathway during TNF-alpha-induced oligodendroglia necroptosis. Our results demonstrate a critical role of Drp1 hyper-activation in OL cell death and suggest that an inhibitor of Drpl hyper-activation such as P110 is worth exploring for its ability to halt or slow the progression of MS. (C) 2017 Elsevier Inc. All rights reserved.